Hay fever and the effect of influenza vaccines

Shaw Watanabe, Tetsuro Yamamoto, Tadao Enomoto, Muneaki Iizuka, Hideyo Yamaguchi

Abstract


Hay fever is an increasing disease in Japan, and the prevalence of cedar pollinosis exceeds 20% nationwide. More than 50 kinds of pollen have been reported so far in Japan. Pollinosis often complicated other allergic conditions. Since patients with allergic diseases have lower s-IgA levels than healthy subjects, patients with hay fever have less weak mucosal immunity so that it would affect the efficacy of the influenza vaccine. Eight thousand three hundred thirty-seven (3885 men and 4452 women) participated in this survey to clarify the relationship between allergic diseases and the influenza vaccine's efficacy. In the no hay fever group, the effective vaccine rate against influenza disease was 0.2%, and in the hay fever group, it was 0.21%. No effect of the influenza vaccine was present in this population. Rather, vaccination seemed to increase influenza incidence in people with hay fever. The basic presence of allergic condition influenza vaccination increased susceptibility to influenza infection. (12.9% vs. 13.89%) (p<0.001). A tailor-made strategy for these patients should be necessary for preventing influenza.


Keywords


Hay fever, pollinosis, allergic rhinitis, asthma, atopy, conjunctivitis, influenza, vaccine

Full Text:

 Subscribers Only

References


Watanabe S, Wahlqvist M. Covid-19, and dietary socioecology: Risk minimization. Asia Pac J Clin Nutr 2020;29(2):207-219

Kishikawa R, Hirose T, Nishima S. Report on the prevention and treatment of pollinosis. Ministry of Health and Welfare; 1990:43–48 [in Japanese].

Yamada T, Saito H,2. Fujieda S. Present state of Japanese cedar pollinosis: the national affliction. J Allergy Clin Immunol 2014;133:632–639.e5.

Yamamoto T. IgA and the risk of SRC-Covid 19 infection. Food Style 2020; 24(6): 1-5.

Gentile A, Paget J, Bellei N, Torres JP, Vazquez C, Laguna-Torres VA, Plotkin S. Influenza in Latin America: A report from the Global Influenza Initiative (GII), Vaccine 2019; doi.10.1016/j.vaccine.2019.03.081.

de la Cruz SP, Cebrino J. Trends, coverage and influencing determinants of influenza vaccination in the elderly: A Population-Based National Survey in Spain (2006–2017), Vaccines 2020; 8(2):327. Doi.10.3390/vaccines8020327.

Higginson R, Minimising infection spread of influenza in the care setting, Practice Nursing 2019; 30(Sup10):S10-S15.

Doi.10.12968/pnur.30.Sup10.S10.

Ministry of Health, Labour and Welfare. Kamiya S. FY 1999 Health and Labor Sciences Research Grant Subsidy Emerging/Re-emerging Infectious Diseases Research Project "Study on the Effect of Influenza Vaccine, Tokyo 1999.

Ministry of Health, Labour and Welfare. FY2016 Health and Welfare Administration Promotion Survey Project Subsidy (Research Project for Promoting Emerging/Re-emerging Infectious Diseases and Vaccination Policy, Tokyo 2016.

Saito Y, Fujii M, Watanabe T, Maruyama K, Kowatari Y, et al. Randomized, double-blind, placebo-controlled, parallel group study of the effect of Lactobacillus paracasei K71 intake on salivary release of secretory immunoglobulin A. Bioscience of Microbiota, Food Health 2017; 36 (2), 55–63.

Izawa S, Hirata U, Kodama M, Nomura S. The effects of daily events and moods on secretory immunoglobulin A in saliva. Jpn J Physiol Psychol Psychophysiol 2007; 25: 237–244. [CrossRef]

Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006; 208: 270–282. [Medline] [CrossRef]

Mora JR, von Andrian UH. Differentiation and homing of IgA-secreting cells. Mucosal Immunol 2008; 1:96-109.

Hirota Y. Q&A on influenza, “Vaccine effectiveness/safety assessment and application to VPD (vaccine preventable diseases) countermeasures” Analytical Epidemiology Research (Principal Researcher: (Health and Medical Management University)), Ministry of Health, Labour and Wellfare. Tokyo, 2019

Keshavarz M, Namdari H, Farahmand M, Mehrbod P, Mokhtari-Azad T, Rezaei F. Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population, Virology Journal 2019; 16: 1. Doi.10.1186/s12985-019-1187-8.

Zheng B, Zhou J, Wang H, Host microRNAs and exosomes that modulate influenza virus infection, Virus Research, 10.1016/j.virusres.2020.197885, (197885), (2020).

Keshavarz M, et al. Where are we and where do we go? In; Influenza vaccine: Chapter 7. 2019, https://doi.org/10.1002/rmv.2014

Keshavarz M, Namdari H, Arjeini Y, Mirzaei H, Salimi V, et al. Induction of protective immune response to intranasal administration of influenza virus‐like particles in a mouse model, Journal of Cellular Physiology 2019; 234(9):16643-6652, doi.10.1002/jcp.28339.

Keshavarz M, Namdari H, Farahmand M, Mehrbod P, Mokhtari-Azad T, Rezaei F, Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population, Virology Journal, 10.1186/s12985-019-1187-8, 16, 1, (2019).

Zheng B, Zhou I, Wang H, Host microRNAs and exosomes that modulate influenza virus infection, Virus Research 2002; 10.1016/j.virusres.2020.197885.

Keshavarz M, et al. Influenza vaccine: Where are we and where do we go? https://doi.org/10.1002/rmv.2014




DOI: http://dx.doi.org/10.18103/imr.v6i5.888

Refbacks

  • There are currently no refbacks.
Copyright 2016. All rights reserved.